Aurobindo Pharma receives five product approvals from USFDA including two Paragraph IV products
Aurobindo Pharma Ltd is pleased to announce that it has received 5 product approvals from the US Food & Drug Administration since October 2007 for the US market. These approvals include two Paragraph IV products - Finasteride Tablets USP and Glyburide & Metformin Hydrochloride Tablets.
The product approved are as follows:
1. Glyburide Tablets USP - 1.25, 2.5 & 5mg
Aurobindo now has a total of 59 ANDAs approved by the USFDA.
About Aurobindo Pharma Limited:
March 03, 2009